a few people working at a table

Press Releases

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Ocular Therapeutix, Inc. (Nasdaq: OCUL) in its $82.5 Million Non-Dilutive Financing

Transaction Information Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular Therapeutix", or "the Company), a...

Ladenburg Thalmann acts as Lead Bookrunner for Eagle Point Income Company, Inc. on its Term Preferred Offering of $28 Million

Ladenburg Thalmann served as Lead Bookrunner for this offering. Since 2017, Ladenburg has led 52 fixed income...

Ladenburg Thalmann Acts as Co-Manager for Harrow in its $60.0 Million Public Offering

Transaction Information Harrow Health, Inc. (NASDAQ: HROW) priced an underwritten registered public offering of...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Kiora Pharmaceuticals, Inc. in its $6.3 Million Underwritten Public Offering

Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced the closing of an underwritten...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Coeptis Therapeutics in its $3.5 Million Underwritten Offering

Transaction Information Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) announced the closing of an...

Ladenburg Thalmann Acts as Lead Manager for Axsome Therapeutics in its $225 Million Public Offering

Transaction Information Axsome Therapeutics, Inc. (NASDAQ: AXSM) announced the closing of its previously...

Ladenburg Acts as Exclusive Placement Agent in a $3.32 Million Registered Direct Offering for Biodexa Pharmaceuticals PLC

Transaction Information Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), announced the closing of a registered...

Ladenburg Acts as Exclusive Placement Agent in $6 Million Registered Direct and Private Placement Offerings for Palisade Bio, Inc.

Offering Priced Above Market Under Nasdaq Rules Transaction Information Palisade Bio, Inc. (Nasdaq: PALI)...

Ladenburg Acts as Sole Book-Running Manager in $12.4 Million Offering for Windtree Therapeutics, Inc.

Transaction Information Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced the closing of its underwritten...

  • 1
  • ...
  • 5
  • ...
  • 36